|
This follow-up report is being submitted to relay additional and/or corrected information.The following sections were updated: h3, h6 type of investigation, investigation findings, investigation conclusions.The following sections were corrected: d1, remove information from d4, d10, remove information from g4, remove information from h4, h6 clinical code, problem code, and component code.D10: (b)(6) 02-022-47-4013 - truliant tib imp cr ins std sz 4, 13mm.(b)(6) 02-022-45-4050 - truliant tib fit tray cem sz 4f / 5t.(b)(6) 02-020-13-0240 - truliant cr cem fem cr cem left sz 4.H3: the reason for the reported revision due to instability cannot be conclusively determined; however, it may be due to soft tissue imbalance, patient anatomy, implant positioning, and/or implant selection.Subluxation and dislocation are known risks, as outlined in the ifu.
|